Genetic modification of cystic fibrosis with ΔF508 mutation of CFTR gene using the CRISPR system in peripheral blood mononuclear cells

Publish Year:

1400

نوع سند:

مقاله ژورنالی

زبان:

English

View:

268

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-24-1_011

تاریخ نمایه سازی: 19 دی 1399

Abstract:

Objective(s): Cystic fibrosis (CF) is an inherited autosomal recessive disease that is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The present study aimed to investigate the genetic modification of CF with ΔF508 mutation of the CFTR gene using CRISPR in peripheral blood mononuclear cells (PBMCs). Materials and Methods: Two single guide RNAs were designed to target sequences in the CFTR gene. The transfection efficiency of PBMC cells was examined through evaluation of green fluorescent protein (GFP) expression using fluorescent microscopy. Moreover, a sgRNA-Cas9 plasmid was tested to target the CFTR gene. The ΔF508 gene modification was evaluated and confirmed by PCR and Sanger sequencing methods. Results: Our results indicate the feasibility of site-specific gene targeting with the CRISPR/Cas9 system. 33% of the samples were corrected using CRISPR in mutant locus and confirmed by sequence blast at NCBI databases and primers outside the arm locus. CRISPR/Cas9 approach represents an efficient tool to repair the ΔF508 mutation of the CFTR gene in PBMC Cells. Conclusion: Therefore, the CRISPR system can be highly efficient and specific and provides a powerful approach for genetic engineering of cells and model animals. Generally, the proposed method opens new insights into the treatment of human diseases.

Keywords:

CFTR gene , CRISPR , Cystic fibrosis , Peripheral blood mononuclear cells , ΔF508 Mutation

Authors

SepidehKhatibi
Sepideh Khatibi

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad RezaModaresi
Mohammad Reza Modaresi

Division of Pediatrics Pulmonary Disease, Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran

RezaKazemi Oskuee
Reza Kazemi Oskuee

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

MohammadSalehi
Mohammad Salehi

Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

HamidAghaei
Hamid Aghaei

Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Xue R, Gu H, Qiu Y, Guo Y, Korteweg ...
  • 2. Fanen P, Wohlhuter-Haddad A, Hinzpeter A. Genetics of cystic ...
  • 3. Kang SH, Dalcin PD, Piltcher OB, Migliavacca RD. Chronic ...
  • 4. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata ...
  • 5. Lander ES. The heroes of CRISPR. Cell 2016;164:18-28. ...
  • 6. Mojica FJ, Díez‐Villaseñor C, Soria E, Juez G. Biological ...
  • 7. Jansen R, Embden JD, Gaastra W, Schouls LM. Identification ...
  • 8. Wiedenheft B, Sternberg SH, Doudna JA. RNA-guided genetic silencing ...
  • 9. Karginov FV, Hannon GJ. The CRISPR system: small RNA-guided ...
  • 10. Ran FA, Hsu PD, Wright J, Agarwala V, Scott ...
  • 11. Mahdavi S, Isazadeh A. Lactobacillus casei suppresses hfq gene ...
  • 12. Tabebordbar M, Zhu K, Cheng JK, Chew WL, Widrick ...
  • 13. Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo ...
  • 14. Wang G, McCain ML, Yang L, He A, Pasqualini ...
  • 15. Xu P, Tong Y, Liu XZ, Wang TT, Cheng ...
  • 16. Park CY, Kim DH, Son JS, Sung JJ, Lee ...
  • 17. Yin H, Xue W, Chen S, Bogorad RL, Benedetti ...
  • 18. Chen S, Sanjana NE, Zheng K, Shalem O, Lee ...
  • 19. Chen Y, Zheng Y, Kang Y, Yang W, Niu ...
  • 20. Tang L, Zeng Y, Du H, Gong M, Peng ...
  • 21. Liang P, Xu Y, Zhang X, Ding C, Huang ...
  • 22. Ramalho AS, Beck S, Meyer M, Penque D, Cutting ...
  • 23. Pourahmad J, Salimi A. Isolated Human Peripheral Blood Mononuclear ...
  • 24. Van Camp K, Cools N, Stein B, Van de ...
  • 25. Un K, Kawakami S, Suzuki R, Maruyama K, Yamashita ...
  • 26. Chono H, Goto Y, Yamakawa S, Tanaka S, Tosaka ...
  • 27. Shaikhpoor M, Khanahmad H, Shokrgozar M, Soleimani M, Zainali ...
  • 28. Majumdar M, Ratho R, Chawla Y, Singh M. Evaluating ...
  • 29. Clements BA, Incani V, Kucharski C, Lavasanifar A, Ritchie ...
  • 30. Kadivar M, Memari N, Fard-Esfahani P. Optimization and Comparison ...
  • 31. Firth AL, Menon T, Parker GS, Qualls SJ, Lewis ...